Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inhaled Medications01:23

Inhaled Medications

256
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
256
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

2.8K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
2.8K
Non-Oral Extravascular Drug Absorption Routes01:15

Non-Oral Extravascular Drug Absorption Routes

214
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
214
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

274
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
274
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

428
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
428

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Design and characterization of a resveratrol spray-dried inhalable formulation for pulmonary delivery with <i>in vivo</i> pharmacokinetic and toxicological evaluation.

Drug delivery·2026
Same author

In vitro comparison of aerosol deposition by albuterol pMDI using corrugated tubing versus a commercial spacer.

International journal of pharmaceutics·2026
Same author

Multi-mechanistic mitochondria-mediated N-methylated YKWYYRGAA-decorated nano-chitosan conjugate carrier for treatment of NRAS-mutant-harbouring lung carcinoma.

Carbohydrate polymers·2026
Same author

Repurposing insulin for Alzheimer's disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain.

Drug delivery and translational research·2026
Same author

Soft‑mist inhaler spray dynamics and laryngeal deposition in upper airway models.

Expert opinion on drug delivery·2026
Same author

The effect of mouthpiece shape and size on low-GWP metered dose inhaler performance.

International journal of pharmaceutics·2026
Same journal

Safety and Pharmacokinetic Data for Inhaled Administration of Nintedanib Dry Powder Inhalation for Treatment of Pulmonary Fibrotic Diseases.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Selecting the Optimal Inhaler in Asthma: Respiratory and Peripheral Muscle Strength as Predictors of DPI and MDI Response.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Usability of Levodopa Cyclops<sup>®</sup> Compared to INBRIJA<sup>®</sup> During an off Episode in Parkinson's Disease Patients.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Design of Dry Powder Inhalers: 1. Does Size Matter?

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung Diseases.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Inhaler Adherence and Treatment Behaviors in COPD: A Study from Both Sides of the Aegean Sea.

Journal of aerosol medicine and pulmonary drug delivery·2026
查看所有相关文章

相关实验视频

Updated: Jun 28, 2025

Intratracheal Administration of Dry Powder Formulation in Mice
07:55

Intratracheal Administration of Dry Powder Formulation in Mice

Published on: July 25, 2020

10.4K

用于吸入的脂质体

Hui Xin Ong1, Daniela Traini1, Paul M Young2

  • 1Woolcock Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.

Journal of aerosol medicine and pulmonary drug delivery
|April 19, 2024
PubMed
概括
此摘要是机器生成的。

脂质体,生物相容的药物载体,为癌症和感染等肺部疾病提供多功能肺部输送. 它们的可调节性质提高了药物的有效性,并减少了针对性肺部治疗的毒性.

关键词:
抗生素 抗生素是一种抗生素.有控制释放的释放.吸入吸入的方法脂质体是一种脂质体.呼吸道疾病是一种呼吸道疾病.

更多相关视频

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.7K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

845

相关实验视频

Last Updated: Jun 28, 2025

Intratracheal Administration of Dry Powder Formulation in Mice
07:55

Intratracheal Administration of Dry Powder Formulation in Mice

Published on: July 25, 2020

10.4K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.7K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

845

科学领域:

  • 肺部医学 肺部医学
  • 纳米技术纳米技术
  • 药物输送系统 药物输送系统

背景情况:

  • 用肺类脂素配制的脂质体为肺部应用提供生物相容性.
  • 它们的多功能性允许定制设计以满足特定的交付需求.
  • 脂质体用于治疗肺癌,囊性纤维化和感染.

研究的目的:

  • 为肺部疾病提供脂质体配方和输送策略的概述.
  • 突出脂质体在肺部医学中的好处.
  • 讨论脂质体在治疗各种肺部疾病中的应用.

主要方法:

  • 脂肪体配方技术的概述 脂肪体配方技术的概述
  • 针对性交付的物理化学性质操纵的讨论.
  • 对肺部注射的输送和释放机制的审查.

主要成果:

  • 脂质体显示出改善的药理动力学和降低的毒性.
  • 实现了治疗效率的提高和难以溶解的药物的输送.
  • 益处包括口味掩饰,防腐保护和向细胞疗法.

结论:

  • 脂质体代表了肺部医学的多功能和有效的药物输送系统.
  • 量身定制脂质体特性使得各种肺部疾病的创新治疗成为可能.
  • 这种方法对改善肺部疾病患者的治疗结果具有显著的前景.